Coronary Physiology Is Useful in Chronic Kidney Disease

Coronary physiology, FFR and iFR, has been shown safe to defer lesions and effective to save stents by different randomized studies and registries. However, patients with chronic kidney disease have not been thoroughly analyzed yet, which brings us to the question about what to do in the face of their negative evolution, when atherosclerosis develops faster, and stress tests are required before we would normally expect.

taller de imágenes y fisiología intracoronaria

This is a retrospective study including 439 patients. 319 (72.7%) presented conserved kidney function assessed with glomerular filtration (eGFR > 60 mL/min/1.73 m2,), and 120 showed evidence of chronic kidney disease (CKD) (glomerular filtration eGFR < 60 mL/min/1.73 m2).

251 patients with conserved kidney function were deferred with FFR (78,7%) and 78 with iFR (21,3%), while 94 CKD patients were deferred with FFR (78,3%) and 26 with iFR (21,7%).

Primary end point was a composite of all cause death, MI or unplanned revascularization. Secondary end point was all cause death, cardiac death, MI and unplanned revascularization. 

Patients with CKD were older, and presented more hypertension, diabetes, peripheral vascular disease and use of anticoagulation, but lower use of ASA. 

Read also: Tricuspid Regurgitation: Edge-to-Edge Treatment with PASCAL.

There were no differences in number of interrogated lesions or their location. The left anterior descending artery was the most involved. 

FFR was used 80% of times.

After 4 years, primary end point was higher in patients with CKD (25% vs. 14% p=0.01). Also, all-cause mortality (13.3% vs. 5.3%, p=0.006) and cardiovascular mortality (5.8% vs. 1.3% p=0.01) were higher. Unplanned revascularization was also higher, though not significantly. There were no differences in MI or target vessel related MI. 

Read also: Progress-CTO Score: A Key New Tool to Plan CTO.

Patients with 4 or 5 stage CKD presented more events vs. patients with conserved kidney function.

Evolution was analyzed according to lesion assessment strategy and there were no differences between FFR and iFR.

Conclusion

Patients with CKD and deferred coronary lesions after pressure-wire evaluation develop more events in the long term compared against patients presenting conserved kidney function. However, this increased number of events in CDK patients was rarely related to the deferred vessel, which suggests an epiphenomenon of intrinsically higher cardiovascular risk in CKD patients.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Safety of coronary revascularization deferral based on fractional flow reserve and instantaneous wave-free ratio in patients with chronic kidney disease.

Reference: Alejandro Travieso, et al. Cardiol J 2022, 29, 4: 553–562.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...